Skip to main content
Equibles

UBS Group AG

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8
Back to ATNM Full portfolio

Position in ATNM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,621
-$7,923 QoQ
Shares Held
6,758
-53.8% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 47 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATNM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ATNM ranks #462 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in ATNM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,621 6,758
2026-03-31 $14,544 14,618
2025-12-31 $129 96
2025-09-30 $23,321 14,576
2025-06-30 $35,825 25,590
2025-03-31 $637,778 396,136
2024-12-31 $111,908 88,816
2024-09-30 $69,520 36,979
2024-06-30 $168,526 22,774
2024-03-31 $217,016 27,716
2023-12-31 $151,165 29,757
2023-09-30 $72,004 12,163
2023-03-31 $25,552 2,704
2022-12-31 $34,452 3,235
2022-09-30 $13,549 1,836
2022-06-30 $173 36
2021-12-31 $300 50
2021-09-30 $1,329 150
2021-06-30 $22,487 2,843
2021-03-31 $1,143 150
2020-06-30 $25,734 73,109
2020-03-31 $25,379 130,822